PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Trihexyphenidyl hydrochloride - Hypersalivation in adults
PAD Profile : Trihexyphenidyl hydrochloride - Hypersalivation in adults
Keywords :
excessive saliva, hypersialosis, drooling, sialorrhoea
Traffic Light Status
Status 1 of 1.
Status :
Blue
Important
Formulations :
- Oral solution
- Tablets
Important Information :
Off-label use. Transfer of prescribing responsibility to primary care after initiation and stabilisation of treatment - minimum of 1 month supply from the specialist team
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
No comments returned.
Documents :
Guidelines
The following guidelines are available for this indication.
Other Drugs
- Amitriptyline hydrochloride
- Ipratropium bromide
- Hyoscine hydrobromide
- Procyclidine hydrochloride
- Atropine sulfate
- Glycopyrronium bromide
Other Indications
Additional Documents
No additional documents returned.
Committee Recommendations
Date
Committee Name
Narrative
04 December 2024
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)
The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.
Associated BNF Codes
04. Central Nervous System
04.09.02. Antimuscarinic drugs used in parkinsonism